Ambu A/S
CSE:AMBU B
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Ambu A/S
CSE:AMBU B
|
DK |
|
I
|
Ichikawa Co Ltd
TSE:3513
|
JP |
|
C
|
Chayo Group PCL
SET:CHAYO
|
TH |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
CA |
|
Melexis NV
OTC:MLXSF
|
BE |
|
C
|
Cognor Holding SA
WSE:COG
|
PL |
|
J
|
Janone Inc
F:5AR1
|
US |
|
Fidea Holdings Co Ltd
TSE:8713
|
JP |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is AMBU B's stock price target?
Not Available
AMBU B doesn't have any price targets made by Wall Street professionals.
What is Ambu A/S's Revenue forecast?
Projected CAGR
11%
For the last 9 years the
compound annual growth rate for
Ambu A/S's revenue is
13%.
The projected
CAGR
for the next 3 years is
11%.
What is Ambu A/S's Operating Income forecast?
Projected CAGR
24%
For the last 9 years the
compound annual growth rate for
Ambu A/S's operating income is
9%.
The projected
CAGR
for the next 3 years is
24%.
What is Ambu A/S's Net Income forecast?
Projected CAGR
18%
For the last 9 years the
compound annual growth rate for
Ambu A/S's net income is
10%.
The projected
CAGR
for the next 3 years is
18%.